BioWorld MedTech

Sep. 20, 2013

Crosstrees gains FDA clearance for PVA device

Crosstrees Medical (Boulder, Colorado) reported that it has received 510(k) clearance from the FDA for the Crosstrees PVA Pod System for Percutaneous Vertebral Augmentation (PVA). Read More

Agilent Technologies to split into two public companies

Device China annual conference: China device association calls for government guidance

Washington roundup: ReSure hits efficacy endpoint; protocol deviations a problem

Financings roundup: Infraredx gets $25M TVC imagingsystem investment from Nipro

Agreements/contracts: Ventana collaborates with Boehringer for diagnostics

Restructuring roundup: Citing ACA, Cleveland Clinic to cut $300M, warns of layoffs

Court report: Alleged secret deal finds Boston Sci facing hefty suit

HIT roundup: Bruker unveils ParaVision 6 preclinical MRI software

Deals roundup: IPC in plan to acquire the assets of MPHM

Med-Tech Notes

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 11, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...